The route to Government funding My team is responsible for delivery the BMC, SBRI and Investor relations activities across Health and Life sciences. Ran a few SBRI but largely funded through NHSE the SBRI Healthcare programme. Have slides about the others Dr Cynthia Bullock Senior Innovation Lead – Enabling Programmes Innovate UK HealthTech Cardiff, Dec 2018

UK Research & Innovation UK Research and Innovation combines Innovate UK with the Research Councils and Research England UKRI is a new body which works in partnership to create the best possible environment for research and innovation to flourish in the UK We have the opportunity to bring under one roof the very best of UK research and innovation, to push knowledge frontiers, to pull through the research that business wants and needs and to deliver both societal and economic impact for the good of the country.

We can’t stop thinking about the future The UK’s innovation agency Innovate UK drives productivity and growth by supporting businesses to realise the potential of new technologies, develop ideas and make them a commercial success. Innovate UK’s mission – growth, productivity, jobs, exports. We fund and connect business led innovation to realise their commercial value which helps accelerate the UK economy. We can’t stop thinking about the future To stay competitive as an advanced economy, we need to do things that others cannot do, or to do things in different and better ways.

We have invested £2.2 billion to date Matched with just over £1.5 billion from industry. 11,000 projects 8,000 organisations 70,000 jobs created And a return on investment of up to £7.30 for every £1 invested. This is public money and we take it very seriously, regularly analysing our portfolio for the impact achieved.

Connect Thematic Focus Knowledge Transfer Advisors Local Presence Global Connections

Catapults We also fund infrastructure called Catapults which aims to bring together the excellent UK research base and innovative businesses in specific areas where the UK has world class expertise.

Innovate UK Fund Portfolio financing growth of innovative firms Transforming existing industries & creating new ones Through building new value chains Through scaling high growth businesses Challenge Programmes ISCF Responsive Programmes Sectors Open Investor Partnership Matched Equity Responsive Programmes Innovation Loans Keynote: Identifying and driving innovation in UK industry Opportunity Centric Investments Business Centric Investments

Creating an economy that boosts productivity and earning power throughout the UK  

Industrial Strategy Grand Challenges AI and Data Economy Ageing Society Clean Growth Future of Mobility

How the ISCF challenges fit with the Industrial Strategy Grand Challenges Clean growth Energy revolution Transforming construction Transforming food production Ageing Society Medicines manufacturing Data to early diagnosis and precision medicine Healthy ageing Future of mobility Faraday battery challenge Extreme robotics National space test facility Artificial intelligence and data economy Audience of the future / Next generation services (pioneer) / Quantum technology (pioneer) The Industrial Strategy Challenge Fund (ISCF) is part of government’s Industrial Strategy. UK Research and Innovation, business and the public sector are being encouraged to work in partnership to address four grand challenges

Underpinning UKRI investments (Wave 1a) up to £283m Wave 1 Challenges (c. £1b) Leading-Edge Healthcare Challenge (including Medicines Mfg) up to £188m Faraday Battery Challenge up to £246m Robotics and AI in extreme environments Challenge up to £93m Next Gen. Affordable Lightweight Materials Mfg (ATI projects) up to £26m Autonomous Vehicles (CCAV projects) up to £38m National Satellite Test Facility up to £99m Underpinning UKRI investments (Wave 1a) up to £283m

Wave 2 Challenges (up to £729.5m) Data to early diagnosis and precision medicine (up to £210m) Prospering from the energy revolution (up to £102.5m) Audience of the future (up to £33m) Healthy ageing (up to £98m) Next generation services (up to£20m) Quantum technology (up to £20m) Transforming construction (up to £170m) Transforming food production (up to £90m)

Submitted for Wave 3 support – Ageing Society Early Detection of Disease - Building a well-characterised, longitudinal cohort of participants who are not yet exhibiting symptoms of disease Developing innovative nutritional products & services for healthier ageing Reimagining our Neighbourhoods of the Future to support health and wellbeing

Open competitions UK based business (any size) UK project and exploitation Alone or in collaboration with businesses/research/charities be an SME if you want to work alone/include an SME if you want to collaborate with others Game changing/disruptive RTO can lead also Project duration between 6 and 18 months: total costs must be between £25,000 and £500,000 and may be either single company or collaborative applications. Project duration between 19 and 36 months: total costs must be between £25,000 and £2,000,000 and must be collaborative.

Biomedical Catalyst funding streams

De-risked, high potential deals Grow UK’s Knowledge Economy Investment Accelerator Maximising Impact & Minimising Risk in Partnership ROI Business scalability De-risked, high potential deals Recycle public purse Grow UK’s Knowledge Economy Innovative technology Commercial opportunity ✔ ✔ High risk Investable people Start: innovate UK identifies novel/disruptive/innovative technologies and uses our funding to change the risk profile to allow investors to invest earlier/wider   Build 1: in parallel investors look at the commercial potential and identify the best quality teams Build 2: it is only when companies achieve simultaneous success in both of these independent processes that companies receive innovate UK grant alongside equity investment Build 3: ROI is created through balancing risk and reward for all: a) direct to companies by linking them into a runway of finance b) a pipeline of high quality deals for investors c) enables innovate UK to drive the UK knowledge economy and d) creates a mechanism to recycle UK investment through GVA measures Work to secure a specific budget is ongoing ✔ ✔

Affordable, flexible and patient Innovation Loans Affordable, flexible and patient 10 3.7% years Single Applicant SMEs only Our innovation loans programme was specifically developed to be affordable, flexible and patient Complimentary not a replacement to R&D grants. Supports R&D developments that are closer to market, Requires project/technology and business evaluation Loan structured for project and commercial success Availability period (up to 3 years) Extension period (up to 2 years) Repayment period (up to 5 years) Up to 100% of project costs Later stage R&D Low interest rate Flexible & patient Up to 10 years Loan size £100k to £1m #innovationloans

Current Competitions SME support to evaluate innovative medical technologies: round 3 - £1.5 million, Closes 30 January 2019 https://apply-for-innovation-funding.service.gov.uk/competition/search

Find out more: https://www.gov.uk/government/organisations/innovate-uk https://www.ktn-uk.co.uk/ https://www.enterprise-europe.co.uk/ https://catapult.org.uk/ https://www.ukri.org/ Customer Support Service Email: support@innovateuk.gov.uk Phone: 0300 321 4357 (Mon-Fri, 9am-5:30pm)